Treatment and Management of HIV Infection in the United States

Case Studies in Managing the Treatment-Experienced HIV Patient

Release Date: October 20, 2016
Expiration Date: October 20, 2017
Estimated Time to Complete: 1.0 hours

Case Studies in Managing the Treatment-Experienced HIV Patient

Release date: October 20, 2016
Expiration date: October 20, 2017
Estimated time to complete: 1.0 hours
Activity URL: http://www.acthiv.org/webinar_switching2.asp

Jointly Provided by:Support for this activity has been made possible through educational grants from Gilead Sciences and ViiV Healthcare

Activity Description
To achieve optimal health outcomes, people living with HIV require continuous access to quality care and treatment for HIV as well as for their other health conditions. (Institute of Medicine 2012) However at the same time, it has been documented that there are an insufficient number of health care professionals with the necessary expertise to care for the growing number of individuals living with HIV. (IOM 2011, Kirch 2012, Reif 2012)

This interactive webinar is the latest in a series of Special Training for Effective Providers in HIV (STEP-HIV) initiatives developed by ACTHIV and the American Academy of CME, Inc. to promote HIV workforce development through education for healthcare professionals who are in training or who are in practice but are new to HIV medicine. This webinar will focus on managing treatment-experienced patients, with special attention to switching or simplifying therapy for patients whose viral loads are suppressed on ART, types of switches that should not be made without resistance test results, and induction-maintenance strategies.

Activity Faculty
Joel E. Gallant, MD, MPH
Medical Director of Specialty Services
Southwest CARE Center
Santa Fe, New Mexico

Faculty Bio

Joel E. Gallant, MD, MPH, is the Medical Director of Specialty Services at the Southwest CARE Center in Santa Fe, New Mexico.  He is Adjunct Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine in Baltimore, where he was previously the Associate Director of the Johns Hopkins AIDS Service.  He is a Clinical Professor of Medicine at the University of New Mexico School of Medicine. He conducts clinical trials on the treatment of HIV infection and viral hepatitis and has been an investigator in the HIV Prevention Trials Network (HPTN), the Multicenter AIDS Cohort (MACS), and the AIDS Clinical Trials Group (ACTG). 
He is a fellow in the Infectious Diseases Society of America and the American College of Physicians.  He is Immediate Past Chair of the HIV Medicine Association and is on the Board of Directors of the International Antiviral Society-USA.  He is a member of the IAS-USA antiretroviral therapy guidelines panel and the IDSA/HIVMA Panel for Primary Care Guidelines for the Management of Persons Infected with HIV.  He is on the Infectious Disease Specialty Board of the American Board of Internal Medicine. He is the recipient of the 2006 HIV Clinical Educator Award from the IDSA/HIVMA. Dr. Gallant writes and speaks extensively on HIV infection and antiretroviral therapy. 

Activity Agenda

  • Switching or simplifying therapy
  • Types of switches that should not be made without resistance test results
  • Induction-maintenance strategies

Target Audience
This activity has been designed to meet the educational needs of physicians (both specialists and primary care/family medicine), nurses, nurse practitioners, and physician assistants who are in training or who are in practice but are new to HIV medicine. Other healthcare providers may also participate.

Learning Objectives
After participating in the activity, learners should be better able to:

  1. Explain the rationale for switching or simplifying therapy in patients whose viral loads are suppressed on ART.
  2. Discuss the types of switches that should not be made in treatment-experienced patients without resistance test results.
  3. Identify the strengths and weaknesses of induction-maintenance strategies that have been studied to date in clinical trials.

Accreditation and Credit Designation

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Academy of CME, Inc., (Academy) and ACTHIV. American Academy of CME, Inc., is accredited by the ACCME to provide continuing medical education for physicians.

American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

American Academy of CME, Inc., designates this educational activity for 1.0 contact hours (1.0 Pharmacotherapeutic Contact Hours).

Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Faculty
Joel Gallant, MD, MPH, discloses the following relationships: Consulting, Advisory Boards, and DSMBs: Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., ViiV Healthcare/GSK; Research Support: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., Sangamo BioSciences, ViiV Healthcare/GSK

Planning Committee
Sharon Lee, MD, Medical Director, Southwest Boulevard Family Health Care Services of Greater Kansas City, (Kansas); President, ACTHIV, discloses the following relationships: Advisory Board: Gilead Sciences, ViiV Healthcare

John JD Juchniewicz, MCIS, CHCP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME, Inc.: No relevant financial relationships with any commercial interests.

This activity contains discussion of off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, ACTHIV or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Instructions on How to Receive Credit
There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE credit for your participation, please complete the post-test (achieving a passing grade of 100%), and program evaluation. Your certificate will be available for printing immediately.

Hardware/Software Requirements
This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended. You must have the Adobe Flash Player installed on your computer in order to view this program. If you do not have the Adobe Flash Player, you can download this free plug-in from Adobe.com.

Privacy and Contact
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For any questions, please contact: CEServices@academycme.org.

Copyright
© 2016. This CME/CNE-certified activity is held as copyrighted © by American Academy of CME and ACTHIV. Through this notice, the Academy and ACTHIV grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).